The US Department of Health and Human Services has awarded a $10.4 million contract to OraSure Technologies for clinical development of the company’s OraQuick ebola rapid antigen test.
Read More
Seegene’s Allplex GI panel covers 25 bacterial, viral, and parasitic causes of gastrointestinal infectious disease.
Read More
A new screening method may detect twice as many women with ovarian cancer as conventional strategies, according to results from the largest trial of its kind, led by researchers at University College London.
Read More
Providing accurate results in approximately 90 minutes with a specimen from enriched Lim broth, the molecular assay targets a highly conserved region of the CAMP factor gene cfb.
Read More
Breast pathology experts share their views about a controversial JAMA study that has raised public anxiety and professional frustration.
Read More